Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, rare blood disorders, neurology, immunology, and oncology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat, and we’re dedicated to discovering and advancing new therapies, providing hope to patients and their families worldwide.
Sanofi is comprised of three core business units: Specialty Care, Vaccines and General Medicines. Consumer Healthcare is a standalone business unit. Around the world, more than 100,000 people at Sanofi are dedicated to making a difference in patients' daily lives, wherever they live, and enabling them to enjoy a healthier life.
Discover your future!
Specialty Care’s 2023 Commercial MBA Summer Associate Program offers exposure to a fast-paced and collaborative environment. Our MBA Summer Associates work side-by-side with biopharmaceutical leaders, providing an opportunity to make an impact in the lives of patients around the globe. One of the goals of this program is to feed a leadership pipeline of top talent for our Commercial Leadership Development Program (CLDP). The CLDP provides in-depth training over two years through commercially focused rotations across Sanofi Genzyme business units, with the opportunity to work with both US and Global teams. The CLDP launches your career to the next level through a targeted approach.
About the job
Join us in one of the following commercially focused business units: Immunology, Multiple Sclerosis, Oncology, Rare Diseases or Rare Blood Disorders. Summer Project Responsibilities may include activities such as:
Global or US Marketing:
Lead or support development of brand strategy
Analyze and recommend customer segmentation; Develop or optimize brand messaging; Develop a creative campaign
Conduct market research and competitive intelligence projects
Execute marketing tactics, such as marketing communications materials, digital initiatives, stakeholder meetings and public relations activities
Lead commercial evaluation and planning of product development initiatives
Support product launch preparations
Support various analytical projects for promoted brands, new products for future launches, and business development projects.
Provide a deep assessment and understanding of where the current landscape of big data stands, from scientific methodologies to capabilities to the various corporations and what is relevant to rare diseases
Global or US Value and Access:
Support Global Pricing & Reimbursement activities for a therapeutic area or brand
Ranging from P&R global analyses to better prepare for future launches, to direct review of any summer pricing updates/requests that require evaluation of the business case in order to secure headquarters approval
Work with Value and Access leads to conduct strategic activities for an upcoming launch product
Conduct research necessary to understand the market access & pricing potential of BD – business development
New Product Planning
Prepare a business case including global revenue projections for a pre-clinical gene therapy program in a rare metabolic/liver targeted disease.
Complete a disease overview for an internal R&D compound candidate and/or conduct a commercial assessment for a BD or M&A opportunity.
About you
Current enrollment in an accredited MBA program and have completed the first year of study prior to joining our 2023 MBA Summer Associate program
Two years of prior work experience in a relevant industry: pharmaceutical or biotechnology industry, finance, marketing, sales, healthcare consulting, investment banking, etc.
Must be authorized to work in the United States without sponsorship
Desire to serve patients, passion for the patient
Excellent communication skills, interpersonally savvy, ability to collaborate across boundaries
Solutions orientation, with an above-the-line mentality
Strong analytical skills, ability to package and present cohesive insights and learning
Demonstrated ability to take action, challenge the status quo and take smart risks
High ambition for learning and career growth
Cambridge, MA
As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.
Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.